Derek Gilpin

Derek Gilpin serves as Vice President - CMC Strategy and Executive Director - Head of CMC & Product Life Cycle Management at Novavax since October 2021, leading the overall CMC strategy for the company's vaccine portfolio, including development, commercialization, and regulatory interactions. Previous experience includes roles at Sanofi Pasteur, where Derek held positions such as Director of Pharmaceutical Technology Platform Head, overseeing the development of manufacturing processes for a diverse vaccine portfolio, and Deputy Director for Viral and Lyophilized Products, focusing on process optimization and validation. Educational background includes a Master of Science in Biochemistry from the University of Scranton, completed between 2003 and 2005.